We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

111 hedge funds and large institutions have $125M invested in VanEck Biotech ETF in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 14

15% more capital invested

Capital invested by funds: $109M → $125M (+$16.5M)

5% more funds holding

Funds holding: 106 → 111 (+5)

3.26% more ownership

Funds ownership: 29.97% → 33.22% (+3.3%)

14% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 28

67% less call options, than puts

Call options by funds: $757K | Put options by funds: $2.29M

Holders
111
Holders Change
+5
Holders Change %
+4.72%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
24
Reduced
28
Closed
14
Calls
$757K
Puts
$2.29M
Net Calls
-$1.53M
Net Calls Change
-$1.02M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5.06M
2
LPL Financial
LPL Financial
California
+$2.29M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2.18M
4
Corient Private Wealth
Corient Private Wealth
Florida
+$1.1M
5
Bank of America
Bank of America
North Carolina
+$651K

Top Sellers

Rank Fund Capital Flow
1
MIM
Miller Investment Management
Pennsylvania
-$7.74M
2
BRM
Boston Research & Management
Massachusetts
-$1.73M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.51M
4
Goldman Sachs
Goldman Sachs
New York
-$1.34M
5
Citadel Advisors
Citadel Advisors
Florida
-$473K
Name Holding Trade Value Shares
Change 		Change in
Stake
HFAS
51
Hummer Financial Advisory Services
Illinois
$257K -$9.25K -50 -4%
CB
52
Commerce Bank
Missouri
$246K – – –
CWP
53
Cyndeo Wealth Partners
Florida
$246K – – –
CA
54
Continuum Advisory
Idaho
$239K +$233K +1,262 New
Jane Street
55
Jane Street
New York
$227K -$148K -800 -40%
Susquehanna International Group
56
Susquehanna International Group
Pennsylvania
$225K -$1.51M -8,166 -87%
Northwestern Mutual Wealth Management
57
Northwestern Mutual Wealth Management
Wisconsin
$223K -$7.22K -39 -3%
CIBC World Market
58
CIBC World Market
Ontario, Canada
$223K -$9.81K -53 -4%
PAG
59
Private Advisor Group
New Jersey
$218K +$213K +1,150 New
Northern Trust
60
Northern Trust
Illinois
$208K -$189K -1,020 -48%
PTC
61
Philadelphia Trust Company
Pennsylvania
$208K +$204K +1,100 New
FFN
62
Focus Financial Network
Minnesota
$206K +$201K +1,087 New
Fidelity Investments
63
Fidelity Investments
Massachusetts
$199K +$96.2K +520 +98%
EPAM
64
Evelyn Partners Asset Management
$178K +$25.2K +136 +17%
UB
65
UMB Bank
Missouri
$170K – – –
Osaic Holdings
66
Osaic Holdings
Arizona
$168K -$76.6K -414 -32%
WSFS
67
Wilmington Savings Fund Society
Delaware
$151K – – –
HNB
68
Huntington National Bank
Ohio
$132K – – –
Comerica Bank
69
Comerica Bank
Texas
$128K – – –
AF
70
Allworth Financial
California
$80.6K +$56.6K +306 +255%
LFASL
71
Lugano Financial Advisors SA (LFA)
Switzerland
$58.7K – – –
MCM
72
Manchester Capital Management
Vermont
$56.8K – – –
SS
73
SBI Securities
Japan
$54.5K -$5.55K -30 -9%
Bank of Montreal
74
Bank of Montreal
Ontario, Canada
$54.3K – – –
MCM
75
MAI Capital Management
Ohio
$50.2K – – –
1 2
3
4 5

BBH Hedge Fund Activity: Q4 2025 in Review

111 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2025, worth a combined $125M — up 15% from $109M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new BBH positions and 14 closed out — a net gain of 6 holders — while 24 added to existing stakes and 28 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $5.06M. The largest seller was Miller Investment Management, cutting an estimated $7.74M.

  • 111 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2025, up from 106 in Q3 2025.
  • Funds reported $125M of VanEck Biotech ETF stock for Q4 2025, up 15% quarter-over-quarter.
  • 20 funds opened new VanEck Biotech ETF positions in Q4 2025 and 14 closed out, a net change of +6 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2025 was Morgan Stanley, an estimated $5.06M added.
  • The largest VanEck Biotech ETF seller in Q4 2025 was Miller Investment Management, an estimated $7.74M sold.

Based on aggregated 13F filings for Q4 2025.